MEDS has constituted a formulary committee that comprises professionals of diverse backgrounds and levels involved in healthcare delivery.
They are drawn from MEDS, the health institutions it serves, relevant regulatory bodies as well as institutions of higher learning. This committee meets annually to review MEDS list of essential drugs and medical supplies, guided by the World Health Organisation Essential Drugs Concept and national treatment guidelines.
A team of experienced pharmaceutical and Quality Control Laboratory staff constitute a Pharmaceutical Technical Committee (PTC) that regularly inspects suppliers to evaluate adherence to Good Manufacturing and Distribution Practices. These inspections play a major role in the pre-qualification of suppliers. Consequently, MEDS is able to ensure that products are sourced only from suppliers who meet internationally recognized quality standards.
Products offered are screened by PTC to ensure that they meet acceptable product specifications. Suppliers sign contracts that bind them to meet pre-determined quality specifications. All goods received at MEDS are inspected to ensure adherence to contractual requirements. Every batch of medicine supplied must be accompanied with a certificate of analysis.
Consignments that do not meet set criteria are rejected. These measures ensure that any abnormalities in supplies are detected in the early stages of the supply chain.
Clients are encouraged to give feedback on the quality of products supplied. A computerised batch-tracking ensures effective and rapid withdrawal of any defective product from the market place. MEDS has built a wealth of information on the quality of products in the market. Clients thus save valuable time and money that would otherwise be used in seeking similar information.
Partnering with MEDS
MEDS seeks for partnerships in the quest to increase access to quality healthcare products to all. For more information please contact the Chief Executive Officer.